Remove 2024 Remove Art Remove Invention Remove Public Use
article thumbnail

The difference between the credibility and the unambiguous disclosure of a therapeutic effect (T 0209/22)

The IPKat

The recent Board of Appeal case T 0209/22 is yet another decision demonstrating the relatively permissive approach in Europe to medical use inventions. The patent related to the medical use of a combination of known drugs. The prior art included a summary of the phase I clinical trial protocol.

article thumbnail

Guest Post by Profs. Masur & Ouellette: Public Use Without the Public Using

Patently-O

What is it that makes a usepublic” for purposes of the public use bar? Does it matter whether the person doing the using is a member of the public, as opposed to the inventor? Or does it matter whether the use is itself in public, as opposed to taking place in secret behind closed doors?

article thumbnail

The IPKat EPO Boards of Appeal Year in Review 2023

The IPKat

Another source of confusion is the divergent approaches of the UK courts and the EPO with respect to the test for the evidence standard in sufficiency and inventive step analysis. Plausibility demystified - a review of EPO case law before G 2/21 G 2/21: Is the technical effect embodied by the invention as originally disclosed?

Invention 108